BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

Journal of Clinical Oncology

Volumn 20, Issue 11, 2002, Pages 2701-2712

  Berry, Donald A ^a   Iversen Jr , Edwin S ^a   Gudbjartsson, Daniel F ^a   Hiller, Elaine H ^a   Garber, Judy E ^a   Peshkin, Beth N ^a   Lerman, Caryn ^a   Watson, Patrice ^a   Lynch, Henry T ^a   Hilsenbeck, Susan G ^a   Rubinstein, Wendy S ^a   Hughes, Kevin S ^a   Parmigiani, Giovanni ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DECISION MAKING, COMPUTER-ASSISTED; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; PREVALENCE; PROBABILITY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0036605379     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.05.121     Document Type: Article

References (35)

1. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2
2. Modeling risk of breast cancer and decisions about genetic testing
3. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history
4. Population genetics of BRCA1 and BRCA2
5. Overestimation of hereditary breast cancer risk
6. Attitudes, knowledge and risk perceptions of women with breast cancer considering testing for BRCA1 and BRCA2
7. Genetic testing for cancer risk
8. Effects of individualized breast cancer risk counseling: A randomized trial
9. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
10. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study
11. Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction
12. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
13. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
14. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
15. BRCA1 sequence analysis in women at high risk for susceptibility mutations
16. Genetic susceptibility and survival: Application to breast cancer
17. The application of Bayesian methods in genetic counseling
18. Testing for BRCA1 breast-ovarian cancer susceptibility gene: A decision analysis
19. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history
20. Genetic susceptibility and survival: Application to breast cancer
21. Disease causality of missense mutations: A hierarchical approach
22. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center
23. Validity testing of a computer model for calculating carrier probabilities of BRCA1 and BRCA2 mutations
24. Early results of genetic testing for breast cancer susceptibility
25. Validating Bayesian prediction models: A case study in genetic susceptibility to breast cancer
26. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
27. The accuracy of patient reports of a family history of cancer
28. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
29. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
30. Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA2 genes in breast cancer families
31. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
32. The genetics of breast and ovarian cancer
33. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
34. Population-based study of risk of breast cancer in carriers of BRCA 2 mutation